Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma found its way into sports
If you've spent any Sunday this fall watching an NFL broadcast, you may have noticed a shift in the advertising landscape. Alongside the team logos between third-down stops and touchdown drives were cancer screening messages from Novartis…
Kringle Pharma FY Parent Loss Y813.00M Vs Loss Y916.00M
Kringle Pharma Inc. (4884.TO) Japan Year Ended September 30 PARENT 2026 2025 Revenue Y442.00 mln Y72.00 mln Operating Profit (Y813.00 mln) (Y909.00 mln) Pretax Profit (Y810.00 mln) (Y914.00 mln) Net Profit (Y813.00 mln) (Y916.00 mln) Per share…
Mums v Big Pharma: the sodium valproate scandal
A new BBC documentary has reignited the outcry over the sodium valproate scandal – a catalogue of pregnancy harms that England's Patient Safety Commissioner has called “bigger than thalidomide”. The drug at the centre of the…
Calley Means: Big Food, Big Pharma Blocked MAHA Reforms
Former White House adviser Calley Means told Joe Rogan that many Make America Healthy Again (MAHA) initiatives stalled because of the lobbying machine's bipartisan efforts to control Washington. Means, who helped unite Trump and HHS Secretary…
Which Is the Better Buy: iShares' Pharma ETF IHE or First Trust's Biotech Fund FBT?
The iShares U.S. Pharmaceuticals ETF (IHE +0.56%) offers a more cost-effective and less volatile way to play the healthcare sector, while the First Trust NYSE Arca Biotechnology Index Fund (FBT +1.28%) provides concentrated exposure to the…
Buzzing stocks: Bajaj Finance, Tata Power, Adani Enterprises, Sandur Manganese, Alivus Life, Aurobindo Pharma
Updated - November 12, 2026 at 07:37 AM. Bajaj Finance, India's largest private sector non-banking financial company (NBFC), on Wednesday launched a qualified institutional placement (QIP) to raise up to ₹11,700 crore ($1.25 billion)…
NewAmsterdam Pharma (NASDAQ:NAMS) Price Target Raised to $61.00
NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) had its target price raised by investment analysts at Cantor Fitzgerald from $52.00 to $61.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has an…
Stock Market Today Live: Buzzing stocks: Bajaj Finance, Tata Power, Adani Enterprises, Sandur Manganese, Alivus Life, Aurobindo Pharma
Updated - November 12, 2026 at 07:37 AM. Sensex Today, Nifty 50 | Stock Market Live Updates: Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 12th November 2026. Published on November 12…
Royalty Pharma (NASDAQ:RPRX) Hits New 52-Week High - What's Next?
Shares of Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) reached a new 52-week high on Wednesday. The stock traded as high as $69.83 and last traded at $69.07, with a volume of 452,424 shares trading hands. The stock had previously closed at…
Aether Industries: From specialty chemicals to global contract manufacturing. Is the next leg already priced in?
A year ago, oil and gas accounted for less than a fifth of Aether's revenue. In Q2 FY27 it became the company's largest end market at 33.4% of revenue, up from 18.8% a year earlier. That shift captures what is happening at Aether. A company the…
Stock markets climb in early trade led by foreign fund inflows, lower crude oil prices
Benchmark equity indices Sensex and Nifty rallied in early trading session on Thursday (November 12, 2026) amid sustained foreign fund inflows and lower crude oil prices. The 30-share BSE Sensex advanced 166.44 points to 82,013.58 in early trade.
Paysign's Post-Q3 Selloff Opens An Opportunity (NASDAQ:PAYS)
Paysign is rated a Buy at $10 despite losing a major plasma customer, as the selloff is seen as exaggerated. The Pharma segment now drives over half of revenue, growing 110% with higher margins and a larger TAM, offsetting plasma center losses.
China AI App Boom Tapped by Drugmakers to Reach Doctors on Marketing Crackdown
The interface of Zhiyi, an AI-powered platform from JD Health, is displayed next to the app's logo in this illustration picture taken October 21, 2026. REUTERS/Florence Lo/Illustration Drugmakers in China are seizing on a boom in digital assistants…
Cinclus outlines HEEALING1 top line results expected this quarter after 523 patients randomized
Earnings Call Insights: Cinclus Pharma Holding AB (publ) (CPHHF) Q3 2026 CEO & President Christer Ahlberg said Cinclus' lead asset “linaprazan glurate” targets “severe erosive GERD,” describing a “large and…
Nifty Eyes Record As Largecaps Lead Charge
Indian equity benchmarks Nifty 50 and Sensex are now less than 5 per cent away from their lifetime highs, supported by a stronger-than-expected earnings performance for the second quarter of financial year 2026-27 (Q2FY27), attractive valuations…
Receive a Daily briefing on Pharma Industry News
Get Started